POLYSAN Scientific & Technological Pharmaceutical Company
23
4
4
18
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
4.3%
1 terminated/withdrawn out of 23 trials
94.7%
+8.2% vs industry average
30%
7 trials in Phase 3/4
0%
0 of 18 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice
Role: lead
Cytoflavin in the Complex Rehabilitation of Stroke Patients
Role: lead
Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
Role: lead
Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old
Role: lead
REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis
Role: lead
Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza
Role: lead
Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis
Role: lead
International Trial of Efficacy of Cytoflavin in Head Trauma
Role: lead
Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy
Role: lead
Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication
Role: lead
Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome
Role: lead
Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19
Role: lead
Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection
Role: lead
Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors
Role: lead
Cytoflavin in Combination With Reperfusion in Stroke Patients
Role: lead
Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery
Role: lead
Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy
Role: lead
Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients
Role: lead
Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers
Role: lead
Remaxol® in Mechanical Jaundice of Non-malignant Origin
Role: lead